| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/05/1995 | EP0646014A1 The use of hyperimmune milk to increase longevity |
| 04/05/1995 | EP0646012A1 Wound healing and treatment of fibrotic disorders |
| 04/05/1995 | EP0513161B1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 04/05/1995 | EP0431023B1 Gamma inulin compositions |
| 04/05/1995 | EP0218625B1 Infectious bronchitis virus spike protein |
| 04/05/1995 | CA2133401A1 Live vaccine having an increased stability |
| 04/04/1995 | US5403924 Taga gene and methods for detecting predisposition to peptic ulceration |
| 04/04/1995 | US5403902 Polymeric supports |
| 04/04/1995 | US5403718 Methods and antibodies for the immune capture and detection of Borrelia burgdorferi |
| 04/04/1995 | US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label |
| 04/04/1995 | US5403586 LHRH-TraTp fusion proteins |
| 04/04/1995 | US5403582 Vaccine comprising fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus |
| 04/04/1995 | US5403581 Administering immunogenic polypeptide to poultry |
| 03/30/1995 | WO1995008634A1 Method for generating influenza a viruses bearing attenuating mutations in internal protein genes |
| 03/30/1995 | WO1995008632A1 Immunoreactive antigens of hepatitis e virus |
| 03/30/1995 | WO1995008631A2 Target antigens of transmission blocking antibodies for malaria parasites |
| 03/30/1995 | WO1995008622A1 Recombinant infectious laryngotracheitis virus and uses thereof |
| 03/30/1995 | WO1995008572A1 Interaction of t-cell receptors and antigen in autoimmune disease |
| 03/30/1995 | WO1995008569A1 NOVEL PROTEIN sp38 AND CONTRACEPTIVE VACCINE |
| 03/30/1995 | WO1995008568A1 VIRULENCE ASSOCIATED PROTEINS IN BORRELIA BURGDORFERI $i(Bb) |
| 03/30/1995 | WO1995008562A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
| 03/30/1995 | WO1995008348A1 Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs |
| 03/30/1995 | WO1995008347A1 Methods and products for controlling immune responses in mammals |
| 03/30/1995 | WO1995008335A1 Treatment of hiv infection with humic acid |
| 03/30/1995 | CA2172512A1 Interaction of t-cell receptors and antigen in autoimmune disease |
| 03/30/1995 | CA2172387A1 Recombinant infectious laryngotracheitis virus and uses thereof |
| 03/30/1995 | CA2171607A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
| 03/30/1995 | CA2170521A1 Immunoreactive antigens of hepatitis e virus |
| 03/30/1995 | CA2169620A1 Retargeting antibodies |
| 03/29/1995 | EP0645630A2 Method of determining the presence of a pivka and a reagent therefor |
| 03/29/1995 | EP0645629A2 Diagnostic agents for osteoporosis |
| 03/29/1995 | EP0645454A2 Chimeric somatostatin containing protein and coding DNA, immunogenic compositions and method for increasing farm animal productivity |
| 03/29/1995 | EP0645147A1 Determination of lymph nodes enriched in tumor reactive cells, their proliferation, and their use in adoptive cellular therapy |
| 03/29/1995 | EP0644948A1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor |
| 03/29/1995 | EP0644947A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
| 03/29/1995 | EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 03/29/1995 | EP0644931A1 Recombinant herpesvirus of turkeys and uses thereof |
| 03/29/1995 | EP0644930A1 Monoclonal antibody against the extra-villous trophoblast |
| 03/29/1995 | EP0644900A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses |
| 03/29/1995 | EP0644895A1 Active component of parathyroid hypertensive factor |
| 03/29/1995 | EP0644884A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels |
| 03/29/1995 | EP0644773A1 Anti-aids immunomodulator complex |
| 03/29/1995 | EP0563144B1 Diagnosis for porcine malignant hyperthermia |
| 03/29/1995 | EP0403558B1 Antibodies for use in antilymphocyte antibody therapy |
| 03/29/1995 | CN1100656A Improved meningococcal polysaccharide conjugate vaccine |
| 03/28/1995 | US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment |
| 03/28/1995 | US5401727 Process for enhancing the resistance of aquatic animals to disease |
| 03/28/1995 | US5401658 Vectors and methods for making such vectors and for expressing cloned genes |
| 03/28/1995 | US5401656 Screening for Rocky Mountain spotted fever and ehrlichiosis |
| 03/28/1995 | US5401642 Vectors and methods for making such vectors and for expressing cloned genes |
| 03/28/1995 | US5401635 Nucleic acids encoding human prohibitin mutants and detection thereof |
| 03/28/1995 | US5401634 Stable biologically active fluorochemical emulsions |
| 03/28/1995 | US5401627 Warts, cancer |
| 03/28/1995 | CA2108401A1 Receptor induced by lymphocyte activation in imflammatory response |
| 03/28/1995 | CA1334941C Cloning and expression of a host-protective immunogens of ibdv |
| 03/23/1995 | WO1995007992A2 Cloned glutamic acid decarboxylase |
| 03/23/1995 | WO1995007987A2 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
| 03/23/1995 | WO1995007985A1 Eotaxin: eosinophil chemotactic cytokine |
| 03/23/1995 | WO1995007934A2 Il8 inhibitors |
| 03/23/1995 | WO1995007933A1 Methods and composition for the modulation of host immune response to allergens |
| 03/23/1995 | WO1995007922A1 Drug binding protein |
| 03/23/1995 | WO1995007718A2 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 03/23/1995 | WO1995007716A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 03/23/1995 | WO1995007715A1 Cd8+ cell antiviral factor |
| 03/23/1995 | WO1995007707A1 Alteration of immune response using pan dr-binding peptides |
| 03/23/1995 | WO1995007706A1 The semaphorin gene family |
| 03/23/1995 | WO1995007691A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 03/23/1995 | WO1995005460A3 Feline immunodeficiency virus isolate ncsu 1 |
| 03/23/1995 | WO1994029469A3 Plasmids suitable for gene therapy |
| 03/23/1995 | CA2171955A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 03/23/1995 | CA2171869A1 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
| 03/22/1995 | EP0644202A1 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 03/22/1995 | EP0644201A1 Derivatives of gpl60 and vaccines based on gpl60 or a derivative thereof, containing an adjuvant |
| 03/22/1995 | EP0643974A1 Vaccine against lyme disease |
| 03/22/1995 | EP0643770A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/22/1995 | EP0643769A1 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN $i(Phl p) II |
| 03/22/1995 | EP0643728A1 Icam-related protein |
| 03/22/1995 | EP0643726A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
| 03/22/1995 | EP0643719A1 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor |
| 03/22/1995 | EP0643586A1 Compositions useful in diagnosis and prophylaxis of lyme disease |
| 03/22/1995 | EP0643583A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 03/22/1995 | EP0643559A1 Diphtheria toxin receptor-binding region |
| 03/22/1995 | EP0527803B1 Composition for macrophage activation |
| 03/22/1995 | EP0449958B1 Meningococcal class 1 outer-membrane protein vaccine |
| 03/22/1995 | EP0299050B1 Isolation of single chain proteins with fsh suppressing activity from follicular fluid |
| 03/22/1995 | CN1100428A Improved meningococcal polysaccharide conjugate vaccine |
| 03/22/1995 | CN1100426A Lysosomal enzyme-cleavable antitumor drug conjugates |
| 03/22/1995 | CA2132506A1 Diagnostic agent for osteoporosis |
| 03/21/1995 | US5399560 1,2,4-triazine products resulting from the inhibition of advanced glycosylation |
| 03/21/1995 | US5399485 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis caused by Rochalimaea henselae |
| 03/21/1995 | US5399347 Method of treating rheumatoid arthritis with type II collagen |
| 03/21/1995 | US5399341 Use of cytokin-containing aerosols and the cytokin-containing aerosols |
| 03/16/1995 | WO1995007462A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases |
| 03/16/1995 | WO1995007354A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 03/16/1995 | WO1995007353A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 03/16/1995 | WO1995007301A1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 03/16/1995 | WO1995007290A1 Method for purifying egg yolk immunoglobulins |
| 03/16/1995 | WO1995007105A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response |
| 03/16/1995 | WO1995007101A2 Living salmonella vaccine |
| 03/16/1995 | WO1995007100A1 Compounds for the prevention and treatment of helminth infections |